Pathogen-accelerated atherosclerosis occurs early after exposure and can be prevented via immunization.
about
A mouse model for pathogen-induced chronic inflammation at local and systemic sitesVascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Review: Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways.Recognition of Porphyromonas gingivalis gingipain epitopes by natural IgM binding to malondialdehyde modified low-density lipoprotein.Pathogen-mediated proteolysis of the cell death regulator RIPK1 and the host defense modulator RIPK2 in human aortic endothelial cells.Porphyromonas gingivalis strain specific interactions with human coronary artery endothelial cells: a comparative studyAnti-P. gingivalis response correlates with atherosclerosis.Polymicrobial infection with major periodontal pathogens induced periodontal disease and aortic atherosclerosis in hyperlipidemic ApoE(null) mice.Porphyromonas gingivalis accelerates inflammatory atherosclerosis in the innominate artery of ApoE deficient mice.Oral P. gingivalis infection alters the vascular reactivity in healthy and spontaneously atherosclerotic mice.Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculatureA prospective cohort study of periodontal disease measures and cardiovascular disease markers in HIV-infected adults."Gum bug, leave my heart alone!"--epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis.Chronic oral infection with major periodontal bacteria Tannerella forsythia modulates systemic atherosclerosis risk factors and inflammatory markers.Protective role for TLR4 signaling in atherosclerosis progression as revealed by infection with a common oral pathogen.Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids.Why should a doctor be interested in oral disease?Murine models of cardiovascular comorbidity in chronic obstructive pulmonary disease.Microbiota, Immune Subversion, and Chronic Inflammation.Activation of the NLRP3 inflammasome in Porphyromonas gingivalis-accelerated atherosclerosis.Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses.Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.Immunization with gingipain A hemagglutinin domain of Porphyromonas gingivalis induces IgM antibodies binding to malondialdehyde-acetaldehyde modified low-density lipoprotein.Linkage of Infection to Adverse Systemic Complications: Periodontal Disease, Toll-Like Receptors, and Other Pattern Recognition Systems.
P2860
Q28604092-6B0E642E-F390-4115-B470-B83EF6D226DEQ30319434-BFEAC977-74A2-4211-B687-34903C454828Q34181823-E8F8EEAC-126A-4018-B868-E004B1395DD5Q34230397-0D4F723B-AA1C-4748-AD95-6058B4DDB9DAQ34299368-81B5F034-04CF-4478-9FB8-55BA97227ECAQ34540921-6FB8D8C4-7E49-4C4D-949A-C9D923269342Q34594762-2A9AEA7A-3426-4B72-B33E-AD46E1762533Q34603206-E4D61DDE-5992-492D-BCB7-CD3C7A7F45E5Q34671776-2863A043-9F3C-411B-95BD-552BDAD52805Q35054781-030FB8A0-D567-4882-A6CC-A9AE10048DFFQ35127516-CA104BC5-B385-4C07-BBBD-6E5E34F5A735Q35508301-80FC5123-5C40-45E6-8820-2A5D369524C1Q35866675-5F9EAC0F-7D58-4354-826E-E5DF32615F80Q35975302-62929D1F-AE86-4B20-A38E-BCEBB7E504FDQ36252511-D93977DD-FD9F-4A8D-9EA7-729EA65954C9Q36459911-7D7B9EB3-EFCB-45D7-BD54-5FFAEF4753F8Q37799367-F6A223CC-2999-47BF-BF97-7AE9EF0B2385Q38781034-8D3419F3-FBE4-413E-94F5-9FD2F42C3E46Q39203697-895E47F1-0DE3-447B-BC7B-0B74FC136589Q41495086-6752B618-C0BE-4B50-A738-1D067D59FE02Q41862930-7801231A-CB2A-4FDF-AE76-09B199F895CAQ42201407-89B8C6AB-F48C-4E3A-9518-AA27444501BAQ48252650-C698A083-7EB5-41A5-B0D0-DC06F90CE7FFQ53698113-73988043-DA6E-4ED9-8192-7C36CB319C06
P2860
Pathogen-accelerated atherosclerosis occurs early after exposure and can be prevented via immunization.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Pathogen-accelerated atheroscl ...... be prevented via immunization.
@ast
Pathogen-accelerated atheroscl ...... be prevented via immunization.
@en
Pathogen-accelerated atheroscl ...... be prevented via immunization.
@nl
type
label
Pathogen-accelerated atheroscl ...... be prevented via immunization.
@ast
Pathogen-accelerated atheroscl ...... be prevented via immunization.
@en
Pathogen-accelerated atheroscl ...... be prevented via immunization.
@nl
prefLabel
Pathogen-accelerated atheroscl ...... be prevented via immunization.
@ast
Pathogen-accelerated atheroscl ...... be prevented via immunization.
@en
Pathogen-accelerated atheroscl ...... be prevented via immunization.
@nl
P2093
P2860
P1476
Pathogen-accelerated atheroscl ...... be prevented via immunization
@en
P2093
Hiromichi Yumoto
Michael Davey
Takanari Miyamoto
Yusuke Takahashi
P2860
P304
P356
10.1128/IAI.74.2.1376-1380.2006
P407
P577
2006-02-01T00:00:00Z